Post by
retiredcf on Oct 08, 2024 10:29am
MedCurrent
Clearly the market likes this acquisition. After only an hour, our trading volume is already the second highest in the past 3 months. And it's always good to see recurring revenue. As previously mentioned, this is why you don't worry about short term SP fluctuations. Sit back, relax and let management do their thing. GLTA
For the eight-month period ending Aug. 31, 2024, MedCurrent reported estimated revenue of C$2.7 million. As of the acquisition closing date on Oct. 7, 2024, MedCurrent had an annualized recurring revenue of approximately C$2.3 million.